Close
CDMO Safety Testing 2026
Novotech

News

Vaccines Europe Undertakes Its First Regulatory Evaluation

With 100 vaccine candidates as of July 2022, Vaccines Europe has released its first pipeline evaluation of the 15 firms that make up its membership. The analysis uncovered a pipeline that uses a variety of new technology platforms to address...

By 2028, Non-Vaccine mRNA Therapy Will Earn $2 Billion

A recent analysis from GlobalData estimates that by 2028, the approval of pipeline drugs will earn over $2 billion from five marketed messenger RNA (mRNA) non-vaccine products. The analytics firm claimed that despite the fact that there are currently no...

Why You Should Consider MISS Over Traditional Spine Surgery

Traditional spine surgeries take hours, come with lengthy recovery times, and even have extraneous risks that a MISS surgery can bypass. Back and spine surgery is a daunting treatment that can seem risky. However, if you have tried all other...

Etihad Cargo achieves IATA CEIV Pharma Recertification for pharmaceutical logistics

Etihad Cargo, the cargo and logistics arm of Etihad Aviation Group, has been awarded Center of Excellence for Independent Validators (CEIV) Pharma recertification by the International Air Transport Association (IATA). The carrier is one of only 37 airlines to...

How to Get the Most Out of Your Medical Oxygen Sensor?

A one-point or two-point calibration is necessary for most dissolved oxygen sensors. To carry out a one-point calibration, the sensor's meter must have the appropriate data about barometric pressure input into it first. The two-point calibration runs are performed in...

Synthetic DNA Is Tailored By AI For Future Medicine Research

Researchers at Chalmers University of Technology in Sweden have created synthetic DNA that directs the cellular creation of proteins with the aid of an AI. With the help of technology, vaccines, medications for serious illnesses, and alternative dietary proteins...

A Multi-Drug Trial On Cancer Precision Medicine Has Begun

A multi-drug, precision medicine trial involving Roche, the University of Manchester, and Cancer Research UK has begun for patients with rare cancers who need additional treatment options. The DETERMINE study is one of the only platform trials using precision...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate ยป